LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $37,000 | -26.0% | 138,465 | 0.0% | 0.00% | – |
| Q2 2022 | $50,000 | -46.8% | 138,465 | 0.0% | 0.00% | – |
| Q1 2022 | $94,000 | -70.5% | 138,465 | 0.0% | 0.00% | – |
| Q4 2021 | $319,000 | -49.7% | 138,465 | 0.0% | 0.00% | – |
| Q3 2021 | $634,000 | +8.2% | 138,465 | +4.8% | 0.00% | – |
| Q2 2021 | $586,000 | -64.9% | 132,121 | -42.4% | 0.00% | – |
| Q1 2021 | $1,670,000 | +6.6% | 229,415 | +11.8% | 0.00% | – |
| Q4 2020 | $1,566,000 | +26.8% | 205,279 | +50.9% | 0.00% | – |
| Q3 2020 | $1,235,000 | +7.6% | 136,042 | +0.2% | 0.00% | – |
| Q2 2020 | $1,148,000 | +126.9% | 135,718 | +32.3% | 0.00% | – |
| Q1 2020 | $506,000 | -63.0% | 102,559 | -46.0% | 0.00% | – |
| Q4 2019 | $1,366,000 | +36.1% | 189,938 | +104.3% | 0.00% | – |
| Q3 2019 | $1,004,000 | -16.1% | 92,950 | +0.9% | 0.00% | – |
| Q2 2019 | $1,197,000 | +93.1% | 92,151 | +46.7% | 0.00% | – |
| Q1 2019 | $620,000 | -50.5% | 62,833 | -47.8% | 0.00% | – |
| Q4 2018 | $1,252,000 | – | 120,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |